4 resultat
The present invention relates to methods of up-regulating albumin production. The methods involve the use of short RNA molecules capable of increasing the expression of albumin. The invention also relates to the design and synthesis of such short RNA molecules and their use in therapy, such as
REFERENCE TO SEQUENCE LISTING
The present application is being filed along with a Sequence Listing in electronic format. The sequence listing filed, entitled 2058-1007USDIV_SL.txt, was created on Jul. 21, 2017 and is 7,034 bytes in size. The information in electronic format of the Sequence Listing
REFERENCE TO SEQUENCE LISTING
The present application is being filed along with a Sequence Listing in electronic format. The sequence listing filed, entitled 2058-1007USDCON_SEQ_Listing.txt, was created on Mar. 8, 2018 and is 7,076 bytes in size. The information in electronic format of the Sequence
FIELD OF THE INVENTION
The present invention relates generally to a blood replacement product, and more particularly to the combination of Human serum albumin and an amino acid solution.
BACKGROUND OF THE INVENTION
Human Serum Albumin is a Human blood derived product that is used to treat